Similarly, in glioblastoma stem cells, ALDH1A3-driven pyruvate kinase activation promotes XRCC1 lactylation-mediated DNA repair and resistance to chemoradiotherapy. This evidence concerns the gene ALDH1A3 and glioblastoma.